These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study. Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Wirtz JJJM; Kooman JP; Schalkwijk CG PLoS One; 2019; 14(8):e0221058. PubMed ID: 31408493 [TBL] [Abstract][Full Text] [Related]
3. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease. Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453 [TBL] [Abstract][Full Text] [Related]
4. Dietary proteins improve endothelial function under fasting conditions but not in the postprandial state, with no effects on markers of low-grade inflammation. Teunissen-Beekman KF; Dopheide J; Geleijnse JM; Bakker SJ; Brink EJ; de Leeuw PW; Schalkwijk CG; van Baak MA Br J Nutr; 2015 Dec; 114(11):1819-28. PubMed ID: 26400262 [TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. Stenvinkel P; Lindholm B; Heimbürger M; Heimbürger O Nephrol Dial Transplant; 2000 Oct; 15(10):1624-30. PubMed ID: 11007832 [TBL] [Abstract][Full Text] [Related]
6. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Pawlak K; Mysliwiec M; Pawlak D Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664 [TBL] [Abstract][Full Text] [Related]
7. Association of malnutrition-inflammation score, dialysis-malnutrition score and serum albumin with novel risk factors for cardiovascular diseases in hemodialysis patients. As'habi A; Tabibi H; Hedayati M; Mahdavi-Mazdeh M; Nozary-Heshmati B Ren Fail; 2015 Feb; 37(1):113-6. PubMed ID: 25296104 [TBL] [Abstract][Full Text] [Related]
8. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. von Scholten BJ; Reinhard H; Hansen TW; Schalkwijk CG; Stehouwer C; Parving HH; Jacobsen PK; Rossing P J Diabetes Complications; 2016 Mar; 30(2):248-55. PubMed ID: 26651261 [TBL] [Abstract][Full Text] [Related]
9. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease. Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549 [TBL] [Abstract][Full Text] [Related]
10. Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients. Yong K; Dogra G; Boudville N; Lim W Perit Dial Int; 2018; 38(1):18-23. PubMed ID: 29097485 [TBL] [Abstract][Full Text] [Related]
12. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation. David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412 [TBL] [Abstract][Full Text] [Related]
13. Endothelial injury is closely related to osteopontin and TNF receptor-mediated inflammation in end-stage renal disease. Batko K; Krzanowski M; Gajda M; Dumnicka P; Fedak D; Woziwodzka K; Sułowicz W; Kuźniewski M; Litwin JA; Krzanowska K Cytokine; 2019 Sep; 121():154729. PubMed ID: 31153055 [TBL] [Abstract][Full Text] [Related]
14. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis. Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892 [TBL] [Abstract][Full Text] [Related]
15. Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy. Martens RJH; Broers NJH; Canaud B; Christiaans MHL; Cornelis T; Gauly A; Hermans MMH; Konings CJAM; van der Sande FM; Scheijen JLJM; Stifft F; Kooman JP; Schalkwijk CG Clin Kidney J; 2020 Oct; 13(5):855-866. PubMed ID: 33123361 [TBL] [Abstract][Full Text] [Related]
16. The association between bioimpedance analysis and quality of life in pre-dialysis stage 5 chronic kidney disease, hemodialysis and peritoneal dialysis patients. Yongsiri S; Thammakumpee J; Prongnamchai S; Dinchuthai P; Chueansuwan R; Tangjaturonrasme S; Chaivanit P J Med Assoc Thai; 2014 Mar; 97(3):293-9. PubMed ID: 25123008 [TBL] [Abstract][Full Text] [Related]
17. Sex differences in the longitudinal relationship of low-grade inflammation and echocardiographic measures in the Hoorn and FLEMENGHO Study. Remmelzwaal S; Beulens JWJ; Elders PJM; Stehouwer CDA; Zhang Z; Handoko ML; Appelman Y; van Empel V; Heymans SRB; Thijs L; Staessen JA; van Ballegooijen AJ PLoS One; 2021; 16(5):e0251148. PubMed ID: 33945586 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Bonomini M; Reale M; Santarelli P; Stuard S; Settefrati N; Albertazzi A Nephron; 1998 Aug; 79(4):399-407. PubMed ID: 9689154 [TBL] [Abstract][Full Text] [Related]